RWFS
PFE icon

Rayburn West Financial Services’s Pfizer PFE Stock Holding History

Rayburn West Financial Services’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Sell
46,742
-1,888
-4% -$49.4K 0.62% 38
2026
Q1 		$1.37M Buy
48,630
+1,100
+2% +$29.3K 0.8% 35
2025
Q4 		$1.18M Buy
+47,530
New +$1.2M 0.74% 36

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Rayburn West Financial Services's PFE Position: Q2 2026 in Review

Rayburn West Financial Services reduced its Pfizer (PFE) stake by 3.9% in Q2 2026, selling an estimated $49.4K and leaving 46,742 shares worth $1.13M. The position accounts for 0.62% of the portfolio, ranked #38.

Rayburn West Financial Services first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.37M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Rayburn West Financial Services held 46,742 shares of Pfizer worth $1.13M as of Q2 2026.
  • Rayburn West Financial Services sold 1,888 Pfizer shares in Q2 2026, an estimated $49.4K.
  • Pfizer made up 0.62% of Rayburn West Financial Services's portfolio in Q2 2026, its #38 holding.
  • Rayburn West Financial Services first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Rayburn West Financial Services's Pfizer position peaked at $1.37M in Q1 2026.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Rayburn West Financial Services's 13F filing for Q2 2026, filed 7 Aug 2026.